Atlas Trials

A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer

Clinical trial NCT02216786 · COMPLETED

Trial details

NCT number
NCT02216786
Sponsor
Queen Mary University of London
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Estrogen Receptor Positive Breast Cancer
Start date
2014-01-16
Primary completion
2021-12-31
Enrollment
333

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.